R. Hui Et Al. , "Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC," JOURNAL OF THORACIC ONCOLOGY , vol.12, no.11, 2017
Hui, R. Et Al. 2017. Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC. JOURNAL OF THORACIC ONCOLOGY , vol.12, no.11 .
Hui, R., Ozguroglu, M., Daniel, D., Baz, D., Murakami, S., Yokoi, T., ... Chiappori, A.(2017). Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC. JOURNAL OF THORACIC ONCOLOGY , vol.12, no.11.
Hui, R. Et Al. "Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC," JOURNAL OF THORACIC ONCOLOGY , vol.12, no.11, 2017
Hui, R. Et Al. "Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC." JOURNAL OF THORACIC ONCOLOGY , vol.12, no.11, 2017
Hui, R. Et Al. (2017) . "Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC." JOURNAL OF THORACIC ONCOLOGY , vol.12, no.11.
@article{article, author={R. Hui Et Al. }, title={Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2017}